chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia, Vaccination complication, Vaccination site movement impairment
Clinical narrative: I got chills; Fever was around 102F; diarrhea again; I got headache again; I could not lift up my arm; having long lasting side effects that are not going away; The lymph nodes in right arm swelled up; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea again), VACCINATION SITE MOVEMENT IMPAIRMENT (I could not lift up my arm), VACCINATION COMPLICATION (having long lasting side effects that are not going away), HEADACHE (I got headache again) and CHILLS (I got chills) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not reported.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and TRAZODONE for an unknown indication.    On 14-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced DIARRHOEA (diarrhea again) and HEADACHE (I got headache again). On 15-Feb-2021, the patient experienced CHILLS (I got chills) and PYREXIA (Fever was around 102F). In February 2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I could not lift up my arm), VACCINATION COMPLICATION (having long lasting side effects that are not going away) and LYMPHADENOPATHY (The lymph nodes in right arm swelled up). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 for Adverse event, at a dose of 1000 mg four times per day and LOPERAMIDE HYDROCHLORIDE (IMODIUM) in February 2021 for Adverse event, at a dose of UNK dosage form. On 17-Feb-2021, CHILLS (I got chills) and PYREXIA (Fever was around 102F) had resolved. At the time of the report, DIARRHOEA (diarrhea again), VACCINATION SITE MOVEMENT IMPAIRMENT (I could not lift up my arm), VACCINATION COMPLICATION (having long lasting side effects that are not going away), HEADACHE (I got headache again) and LYMPHADENOPATHY (The lymph nodes in right arm swelled up) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 102 f (High) High. On an unknown date, Computerised tomogram: normal (normal) Normal.         It was reported that the lymph nodes in right arm was about the base ball size.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site mass, Vaccination site warmth
Clinical narrative: warm around the injection site; red ring around vaccination; arm soreness; a ball started to form in her arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (a ball started to form in her arm at the injection site), PAIN IN EXTREMITY (arm soreness), VACCINATION SITE ERYTHEMA (red ring around vaccination) and VACCINATION SITE WARMTH (warm around the injection site) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's medical history was not reported.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE MASS (a ball started to form in her arm at the injection site). On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red ring around vaccination) and VACCINATION SITE WARMTH (warm around the injection site). The patient was treated with PARACETAMOL (TYLENOL) in January 2021 for Adverse event, at a dose of UNK dosage form. On 31-Jan-2021, VACCINATION SITE MASS (a ball started to form in her arm at the injection site) had resolved. On 06-Feb-2021, PAIN IN EXTREMITY (arm soreness), VACCINATION SITE ERYTHEMA (red ring around vaccination) and VACCINATION SITE WARMTH (warm around the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included her high blood pressure medication. The patient thinks that the vaccine did not hit the muscle and formed "skin popping," like what IV drug users experience with injections and abscesses. The ball lasted for 9-10 days until the patient started to massage the area and it went away.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity, Vaccination site pain
Clinical narrative: when moves arm there is pain; bruise on her arm 3 inches below the injection site; touches the injection site, it hurts; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), CONTUSION (bruise on her arm 3 inches below the injection site), VACCINATION SITE PAIN (touches the injection site, it hurts) and PAIN IN EXTREMITY (when moves arm there is pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient had no allergies. The patient's medical history included high blood pressure and high cholesterol.  The patient's past medical history included Diabetes and Acid reflux (esophageal). Concomitant products included LOSARTAN, AMLODIPINE, PRAVASTATIN, METFORMIN, OMEPRAZOLE, TRIAMTERENE and HYDROCHLOROTHIAZIDE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 30-Jan-2021, the patient experienced CONTUSION (bruise on her arm 3 inches below the injection site) and VACCINATION SITE PAIN (touches the injection site, it hurts). On an unknown date, the patient experienced PAIN IN EXTREMITY (when moves arm there is pain). At the time of the report, PAIN IN EXTREMITY (Arm was sore) had resolved and CONTUSION (bruise on her arm 3 inches below the injection site), VACCINATION SITE PAIN (touches the injection site, it hurts) and PAIN IN EXTREMITY (when moves arm there is pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported. The patient was scheduled for her second vaccine on 22-Feb-2021.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site scab, Vaccination site swelling
Clinical narrative: Scab at the injection site; Left arm is red at the injection site; Slightly raised at the injection site; Left arm is swollen at the injection site; extend down 3 inches; Left arm became itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm became itchy), VACCINATION SITE SCAB (Scab at the injection site), VACCINATION SITE SWELLING (Left arm is swollen at the injection site; extend down 3 inches), VACCINATION SITE ERYTHEMA (Left arm is red at the injection site) and VACCINATION SITE SWELLING (Slightly raised at the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient has no known medication allergies. The patient had high cholesterol.  The patient's past medical history included Memory impairment. Concurrent medical conditions included Hypothyroidism and Cholesterol high. Concomitant products included LEVOTHYROXINE, VITAMIN D3 and IRON for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (Left arm became itchy). On 18-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Left arm is swollen at the injection site; extend down 3 inches). On an unknown date, the patient experienced VACCINATION SITE SCAB (Scab at the injection site), VACCINATION SITE ERYTHEMA (Left arm is red at the injection site) and VACCINATION SITE SWELLING (Slightly raised at the injection site). At the time of the report, PRURITUS (Left arm became itchy), VACCINATION SITE SCAB (Scab at the injection site), VACCINATION SITE SWELLING (Left arm is swollen at the injection site; extend down 3 inches), VACCINATION SITE ERYTHEMA (Left arm is red at the injection site) and VACCINATION SITE SWELLING (Slightly raised at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not reported/unknown.  The patient reported that she might have scratched the area to cause the scab. The patient had not informed her HCP of the events.  Patient also deny for further follow-up as per the Telephone contact report.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up information received on 25-JUN-2021 and contains no new information.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: shortness of breath; runny nose; red at injection site; swelling at injection site; nauseated; chills; Fever of 104 F; bad headache; Body aches; sore arm at injection site; real tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site) and NAUSEA (nauseated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and HYDROXYCHLOROQUINE for an unknown indication.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (real tired). On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 17-Feb-2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 104 (High) 104 F. On 18-Feb-2021, Body temperature: 100 (High) 100F.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Rhinorrhoea, Vaccination site erythema
Clinical narrative: shortness of breath; runny nose; red at injection site; swelling at injection site; nauseated; chills; Fever of 104 F; bad headache; Body aches; sore arm at injection site; real tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site) and NAUSEA (nauseated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and HYDROXYCHLOROQUINE for an unknown indication.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (real tired). On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 17-Feb-2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 104 (High) 104 F. On 18-Feb-2021, Body temperature: 100 (High) 100F.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: shortness of breath; runny nose; red at injection site; swelling at injection site; nauseated; chills; Fever of 104 F; bad headache; Body aches; sore arm at injection site; real tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site) and NAUSEA (nauseated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and HYDROXYCHLOROQUINE for an unknown indication.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (real tired). On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 17-Feb-2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 104 (High) 104 F. On 18-Feb-2021, Body temperature: 100 (High) 100F.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection, Myalgia, Rash
Clinical narrative: Herpes Skin Rash on nose and lips, muscle pain
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Ear discomfort, Headache
Clinical narrative: Approx. 2 weeks after vaccination I started to experience a clicking / popping noise in my left ear. Vaccine shot was taken in left arm. The noise appears only from movement impact when I walk, jump, run, move my head rapidly, rest my chin on my hand or even when I drive over road bumps. Also, the noise would be more or less depending on the position of my head such as looking straight vs left or up vs down. It is movement related, there is no noise when I rest or sleep. The noise is coming from deep inside my ear. I had no other symptoms apart from general very light discomfort inside the ear. Initially the noise appeared for a few hours, then it disappeared, this happened a few times and within a week became constant and very loud. I have never had any ear related issues before. I visited a general practitioner who looked at the ear and stated there was no infection. Was told it may be due to bad sitting posture and was sent to massage therapy which I?ve done 5 sessions thus far over the course of over 1 month. After 2 months, the clicking noise is now about 80% less and it comes at higher movement impact but still persistent. I revisited another general practitioner at MedBase who referred me to an ear specialist. The ear specialist could not identify the cause of the issue or problem itself and suggested I take some magnesium for muscle relaxation and Nasonex Nasal spray 2 times a day for 1 month as a steroid to relax the Eustachian tube. After 2 days use, I paused using Nasonex due to headache side effects. The ear noise persists and I am worried to take the 2nd vaccine dose not to make it worst. Also, I live a very active lifestyle and I?m worried it may continue to impact my well-being. The noise over the course of 4 months has diminished approx. 80%. Interesting thing is that my father had a same popping noise symptom for 1 month and half after taking his 2nd shot of Pfizer vaccine. He says the noise would stop if moved his head and kept it in one direction. My mother had a short-lived ringing in the ear at night after 2nd short Pfizer vaccine.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chest pain, Fluid retention, Heart rate increased
Clinical narrative: All symptoms were reported at the time as separate incidents that continued over the course of a week and ended with an ER visit. Symptoms were not known to be related to vaccines at the time.  Symptoms: Severe Back/ Pain in right side, severe pain then migrated to the chest, chest tender to the touch, rapid heart rate/best, severe pain in chest feeling as if heart was going to explode, chest pain then migrated to left arm and wrist, swollen and inflamed left arm and hand, unable to lift of bend hand and fingers, fluid retention and ankle swelling. This happened between the day following my second dose and the middle of the next week.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Joint swelling, Musculoskeletal chest pain, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: All symptoms were reported at the time as separate incidents that continued over the course of a week and ended with an ER visit. Symptoms were not known to be related to vaccines at the time.  Symptoms: Severe Back/ Pain in right side, severe pain then migrated to the chest, chest tender to the touch, rapid heart rate/best, severe pain in chest feeling as if heart was going to explode, chest pain then migrated to left arm and wrist, swollen and inflamed left arm and hand, unable to lift of bend hand and fingers, fluid retention and ankle swelling. This happened between the day following my second dose and the middle of the next week.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: All symptoms were reported at the time as separate incidents that continued over the course of a week and ended with an ER visit. Symptoms were not known to be related to vaccines at the time.  Symptoms: Severe Back/ Pain in right side, severe pain then migrated to the chest, chest tender to the touch, rapid heart rate/best, severe pain in chest feeling as if heart was going to explode, chest pain then migrated to left arm and wrist, swollen and inflamed left arm and hand, unable to lift of bend hand and fingers, fluid retention and ankle swelling. This happened between the day following my second dose and the middle of the next week.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included antiviral medication. The patient was scheduled for his second dose on Friday of the report week.   Reporter did not allow further contact
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine
Clinical narrative: Extreme fatigue & migraines.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Panic attack
Clinical narrative: The only adverse effect immediately after the shot was severe, unusual  tiredness which lasted several days. About a month later, I started experiencing  "Panic Attacks".  Here it is, August 12, and I still have had a couple a month. This is very out of the ordinary for me, I really just wanted to know if this happened to anyone else and if it could be vaccine-related. Also would like to know if they stop. A terrible feeling of dread comes over me, along with the inability to sleep. I start pacing and worrying. First few lasted minutes, now lasting hours. Like I stated, no other reason for this. No money, love,, health, or work issues. I work out 6 or 7 days a week.  They just come out of nowhere. I guess I just wanted to know if anyone else is experiencing these, misery loves company, I reckon. I hope they stop or that something can be done. Hopefully this is not a vaccine side-effect, or, if so, not a permanent one.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Vaccination site pain
Clinical narrative: soreness at the injection site; body aches; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site), MYALGIA (body aches) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis, Hypertension, Glaucoma and Anxiety. Concomitant products included BRIMONIDINE TARTRATE, TIMOLOL MALEATE (COMBIGAN) for Glaucoma, METHOTREXATE for Rheumatoid arthritis, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site), MYALGIA (body aches) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown and MYALGIA (body aches) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medication included pills for anxiety and hypertension. The patient did not receive any treatment for the events.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Red came back and swelled and started itching; Red came back and swelled and started itching; Red came back and swelled and started itching; injection site swelled a little bit; got red and itched at the injection site; got red and itched at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (injection site swelled a little bit), VACCINATION SITE PRURITUS (got red and itched at the injection site), VACCINATION SITE ERYTHEMA (got red and itched at the injection site), VACCINATION SITE PRURITUS (Red came back and swelled and started itching) and VACCINATION SITE ERYTHEMA (Red came back and swelled and started itching) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M209) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE SWELLING (injection site swelled a little bit), VACCINATION SITE PRURITUS (got red and itched at the injection site) and VACCINATION SITE ERYTHEMA (got red and itched at the injection site). On 12-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Red came back and swelled and started itching), VACCINATION SITE ERYTHEMA (Red came back and swelled and started itching) and VACCINATION SITE SWELLING (Red came back and swelled and started itching). The patient was treated with HYDROCORTISONE (topical) for Adverse event, at a dose of UNK dosage form and DIMETICONE, PARAFFIN (RASH RELIEF CLEAR) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE SWELLING (injection site swelled a little bit), VACCINATION SITE PRURITUS (got red and itched at the injection site), VACCINATION SITE ERYTHEMA (got red and itched at the injection site) and VACCINATION SITE SWELLING (Red came back and swelled and started itching) had resolved and VACCINATION SITE PRURITUS (Red came back and swelled and started itching) and VACCINATION SITE ERYTHEMA (Red came back and swelled and started itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. The patient stated that  at the time of report it stayed red and did not have a rash, it was just red and itching.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Sinusitis
Clinical narrative: loss of taste; loss of smell; symptoms similar to a sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste), ANOSMIA (loss of smell) and SINUSITIS (symptoms similar to a sinus infection) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced AGEUSIA (loss of taste), ANOSMIA (loss of smell) and SINUSITIS (symptoms similar to a sinus infection). At the time of the report, AGEUSIA (loss of taste), ANOSMIA (loss of smell) and SINUSITIS (symptoms similar to a sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.    This case was linked to MOD-2021-016188 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Influenza like illness, Pruritus
Clinical narrative: itching; Felt like she had the flu; Bad headache; Fatigue; Loss of appetite; Loss of thirst; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), THIRST DECREASED (Loss of thirst), PRURITUS (itching), INFLUENZA LIKE ILLNESS (Felt like she had the flu) and HEADACHE (Bad headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 00IB2IA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), THIRST DECREASED (Loss of thirst), INFLUENZA LIKE ILLNESS (Felt like she had the flu), HEADACHE (Bad headache) and FATIGUE (Fatigue). On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, DECREASED APPETITE (Loss of appetite), THIRST DECREASED (Loss of thirst), INFLUENZA LIKE ILLNESS (Felt like she had the flu), HEADACHE (Bad headache) and FATIGUE (Fatigue) outcome was unknown and PRURITUS (itching) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment medications provided for the event of pruritus.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Date of birth, height and weight, new event were added. Information about 2nd dose was also added.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Thirst decreased
Clinical narrative: itching; Felt like she had the flu; Bad headache; Fatigue; Loss of appetite; Loss of thirst; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), THIRST DECREASED (Loss of thirst), PRURITUS (itching), INFLUENZA LIKE ILLNESS (Felt like she had the flu) and HEADACHE (Bad headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 00IB2IA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), THIRST DECREASED (Loss of thirst), INFLUENZA LIKE ILLNESS (Felt like she had the flu), HEADACHE (Bad headache) and FATIGUE (Fatigue). On an unknown date, the patient experienced PRURITUS (itching). At the time of the report, DECREASED APPETITE (Loss of appetite), THIRST DECREASED (Loss of thirst), INFLUENZA LIKE ILLNESS (Felt like she had the flu), HEADACHE (Bad headache) and FATIGUE (Fatigue) outcome was unknown and PRURITUS (itching) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment medications provided for the event of pruritus.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Date of birth, height and weight, new event were added. Information about 2nd dose was also added.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: little sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore arm) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (little sore arm) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (little sore arm) and CHILLS (Chills) outcome was unknown.            Concomitant medication was not reported. Treatment medication was not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Nausea
Clinical narrative: Chills; joints and shoulders hurt; felt a little nauseated; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), ARTHRALGIA (joints and shoulders hurt) and NAUSEA (felt a little nauseated) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M219) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced CHILLS (Chills), ARTHRALGIA (joints and shoulders hurt) and NAUSEA (felt a little nauseated). On 06-Feb-2021, CHILLS (Chills), ARTHRALGIA (joints and shoulders hurt) and NAUSEA (felt a little nauseated) had resolved.            No concomitant medications were provided.   Patient took Tylenol for the treatment of the events.; Sender's Comments: Based on the current available information which includes a temporal association between the use of mRNA-1273 and the start date of the reported events, a causal relationship with the event cannot be excluded. The reported events are consistent with the known safety profile of the vaccine.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Feeling cold, Nausea, Pain in extremity
Clinical narrative: Sore arm; lot of coughing; Fever; nauseous for little bit; freezing cold last night; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (freezing cold last night), PYREXIA (Fever), PAIN IN EXTREMITY (Sore arm), NAUSEA (nauseous for little bit) and COUGH (lot of coughing) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's medical history was not reported.  Concomitant products included LOSARTAN for Blood pressure abnormal, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FEELING COLD (freezing cold last night). On 04-Feb-2021, the patient experienced PYREXIA (Fever), PAIN IN EXTREMITY (Sore arm), NAUSEA (nauseous for little bit) and COUGH (lot of coughing). At the time of the report, FEELING COLD (freezing cold last night), PYREXIA (Fever), PAIN IN EXTREMITY (Sore arm), NAUSEA (nauseous for little bit) and COUGH (lot of coughing) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 103 (High) 103 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take any treatment medication.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sore arm; lot of coughing; Fever; nauseous for little bit; freezing cold last night; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (freezing cold last night), PYREXIA (Fever), PAIN IN EXTREMITY (Sore arm), NAUSEA (nauseous for little bit) and COUGH (lot of coughing) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's medical history was not reported.  Concomitant products included LOSARTAN for Blood pressure abnormal, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FEELING COLD (freezing cold last night). On 04-Feb-2021, the patient experienced PYREXIA (Fever), PAIN IN EXTREMITY (Sore arm), NAUSEA (nauseous for little bit) and COUGH (lot of coughing). At the time of the report, FEELING COLD (freezing cold last night), PYREXIA (Fever), PAIN IN EXTREMITY (Sore arm), NAUSEA (nauseous for little bit) and COUGH (lot of coughing) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 103 (High) 103 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take any treatment medication.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: injection site is Itch; Injection site is red; Injection site is a little sore; mild tenderness; soreness; little redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (mild tenderness), VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (little redness), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE PRURITUS (injection site is Itch) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (mild tenderness), VACCINATION SITE PAIN (soreness) and VACCINATION SITE ERYTHEMA (little redness). On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE PRURITUS (injection site is Itch) and VACCINATION SITE PAIN (Injection site is a little sore). At the time of the report, VACCINATION SITE PAIN (mild tenderness), VACCINATION SITE PAIN (soreness) and VACCINATION SITE ERYTHEMA (little redness) had resolved and VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE PRURITUS (injection site is Itch) and VACCINATION SITE PAIN (Injection site is a little sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The patient did not use any treatment medication.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Injection site hurting and sore; Red patch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site hurting and sore) and VACCINATION SITE ERYTHEMA (Red patch at injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site hurting and sore) and VACCINATION SITE ERYTHEMA (Red patch at injection site). At the time of the report, VACCINATION SITE PAIN (Injection site hurting and sore) and VACCINATION SITE ERYTHEMA (Red patch at injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication was not reported. Treatment included ice.   This case was linked to MOD-2021-082793 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: no new information.; Sender's Comments:  MOD-2021-082793:Same patient, 2nd dose
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) and ATORVASTATIN for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: No specific follow-up information recorded.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Malaise, Vomiting
Clinical narrative: no appetite; body week; feel sick; Chills; PUKE; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ASTHENIA (body week), MALAISE (feel sick), CHILLS (Chills) and VOMITING (PUKE) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (body week), MALAISE (feel sick), CHILLS (Chills) and VOMITING (PUKE). At the time of the report, DECREASED APPETITE (no appetite), ASTHENIA (body week), MALAISE (feel sick), CHILLS (Chills) and VOMITING (PUKE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.  This case concerns a 63-year-old female with serious unexpected events of decreased appetite, asthenia, malaise, chills and vomiting. Latency within 1 day after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non significant follow up; Sender's Comments: This case concerns a 63-year-old female with serious unexpected events of decreased appetite, asthenia, malaise, chills and vomiting. Latency within 1 day after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever 100°F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100°F) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included Palpitations and BP. Concurrent medical conditions included Drug allergy (allergy to statin) and Arthritis. Concomitant products included AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE (DYMISTA), CORTISONE, LATANOPROST (XALATAN), METOPROLOL SUCCINATE (TOPROL), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), ROSUVASTATIN CALCIUM (CRESTOR), METOPROLOL and DILTIAZEM HYDROCHLORIDE (CARDIZEM CD) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Fever 100°F). On 03-Feb-2021, PYREXIA (Fever 100°F) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) High. On an unknown date, SARS-CoV-2 test: negative (Negative) Covid-19 test Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment for the event included Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: follow-up received addition of concomitant medications, relevant history and addition of second dose; Reporter's Comments: This case concerns a 78-year-old male who experienced NS expected events of PYREXIA.  COVID-19 test negative. The event occurred 7 days after the first dose of mRNA-1273. Treatment included Tylenol. Event outcome resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Erythema, Fatigue, Pruritus, Skin induration
Clinical narrative: it's itching; bump in their skin; it's hot; it's red; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (it's itching), SKIN INDURATION (bump in their skin), DRY SKIN (it's hot), ERYTHEMA (it's red) and FATIGUE (felt tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M204) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, METOPROLOL and CANDESARTAN CILEXETIL (ATACAND) for Blood pressure management, CRESOL for Cholesterol, VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for Depression, CHLORMEZANONE (RESTORIL [CHLORMEZANONE]) for Sleep problem, METFORMIN, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), Multivitamin Centrum Silver and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced FATIGUE (felt tired). On 17-Feb-2021, the patient experienced PRURITUS (it's itching), SKIN INDURATION (bump in their skin), DRY SKIN (it's hot) and ERYTHEMA (it's red). At the time of the report, PRURITUS (it's itching), SKIN INDURATION (bump in their skin), DRY SKIN (it's hot), ERYTHEMA (it's red) and FATIGUE (felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication nclude Benadryl cream on it but they have not done it yet. They took 2 acetaminophens that morning before getting the vaccine
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Ring-like rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Ring-like rash) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Ring-like rash). At the time of the report, RASH (Ring-like rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided